Innovative drug development in China is entering a phase of unprecedented dynamism. A trend powerfully illustrated by a 59% surge in approvals during the first half of 2025. This accelerated pace is fundamentally reshaping the sector, fueled by strategic policy support and a rapidly expanding global footprint. As evidenced by a series of high-value international … Continue reading Innovative Drug Development in China: Accelerates with Robust Pipeline and Global Ambitions